{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:09Z","timestamp":1791928869328,"version":"4.3.4"},"reference-count":51,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"5","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,5,28]]},"DOI":"10.1167\/iovs.66.5.42","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:30:47Z","timestamp":1748428247000},"page":"42","source":"Crossref","is-referenced-by-count":1,"title":["Clofarabine Enhances the Transduction Efficiency of Recombinant AAV2 in the Retina"],"prefix":"10.1167","volume":"66","author":[{"given":"Yuyao","family":"Diao","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"},{"name":"Department of Ophthalmology, Affiliated Qingyuan Hospital, Guangzhou Medical University, Qingyuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangli","family":"Jin","sequence":"additional","affiliation":[{"name":"The Sixth Affiliated Hospital of Jinan University, Jinan University, Dongguan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"},{"name":"Department of Ophthalmology, Affiliated Guangdong Second Provincial General Hospital, Jinan University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shisi","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"},{"name":"Department of Ophthalmology, Zhujiang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guei-Sheung","family":"Liu","sequence":"additional","affiliation":[{"name":"Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia"},{"name":"Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia"},{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"},{"name":"Aier Eye Institute, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guocheng","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia"},{"name":"Ophthalmology, Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiang","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/tvst.7.4.6","article-title":"Inherited retinal degenerations: current landscape and knowledge gaps","volume":"7","author":"Duncan","year":"2018","journal-title":"Transl Vis Sci Technol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet (London, England)"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/21655979.2019.1684863","article-title":"Effect of promoter, promoter mutation and enhancer on transgene expression mediated by episomal vectors in transfected HEK293, Chang liver and primary cells","volume":"10","author":"Xu","year":"2019","journal-title":"Bioengineered"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"12472","DOI":"10.1128\/JVI.01971-14","article-title":"Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms","volume":"88","author":"Weinberg","year":"2014","journal-title":"J Virol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"e0203921","DOI":"10.1128\/jvi.02039-21","article-title":"Epigenetic silencing of recombinant adeno-associated virus genomes by NP220 and the HUSH complex","volume":"96","author":"Das","year":"2022","journal-title":"J Virol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0168-9525(90)90214-Q","article-title":"Ribonucleotide reductase and its regulation during the cell cycle","volume":"6","author":"Fernandez-Sarabia","year":"1990","journal-title":"Trends Genet TIG"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0268-960X(94)90072-P","article-title":"The role of fludarabine in hematological malignancies","volume":"8","author":"Wright","year":"1994","journal-title":"Blood Rev"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/biom12060815","article-title":"Inhibitors of the cancer target ribonucleotide reductase, past and present","volume":"12","author":"Huff","year":"2022","journal-title":"Biomolecules"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1261::AID-CNCR7>3.0.CO;2-T","article-title":"An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinoma","volume":"85","author":"Storniolo","year":"1999","journal-title":"Cancer"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1089\/hum.2004.15.1207","article-title":"Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cells","volume":"15","author":"Zhong","year":"2004","journal-title":"Human Gene Ther"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41587-022-01240-2","article-title":"Fludarabine increases nuclease-free AAV- and CRISPR\/Cas9-mediated homologous recombination in mice","volume":"40","author":"Tsuji","year":"2022","journal-title":"Nat Biotechnol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41586-020-03170-y","article-title":"Elevated NSD3 histone methylation activity drives squamous cell lung cancer","volume":"590","author":"Yuan","year":"2021","journal-title":"Nature"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41586-020-03056-z","article-title":"Sorting nexin 5 mediates virus-induced autophagy and immunity","volume":"589","author":"Dong","year":"2021","journal-title":"Nature"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-015-0346-9","article-title":"Identification of TRAIL-inducing compounds highlights small molecule ONC201\/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway","volume":"14","author":"Allen","year":"2015","journal-title":"Mol Cancer"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"108718","DOI":"10.1016\/j.exer.2021.108718","article-title":"Single cell RNA sequencing (scRNA-Seq) deciphering pathological alterations in streptozotocin-induced diabetic retinas","volume":"210","author":"Sun","year":"2021","journal-title":"Exp Eye Res"},{"key":"bib17","first-page":"2386","article-title":"Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate","volume":"51","author":"Parker","year":"1991","journal-title":"Cancer Res"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1586\/ehm.09.70","article-title":"Clofarabine in leukemia","volume":"3","author":"Ghanem","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1667\/RR2556.1","article-title":"Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers","volume":"176","author":"Kunos","year":"2011","journal-title":"Radiat Res"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-biochem-013118-111843","article-title":"Ribonucleotide reductases: structure, chemistry, and metabolism suggest new therapeutic targets","volume":"89","author":"Greene","year":"2020","journal-title":"Annu Rev Biochem"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.3390\/cancers14194710","article-title":"Identification of monobenzone as a novel potential anti-acute myeloid leukaemia agent that inhibits RNR and suppresses tumour growth in mouse xenograft model","volume":"14","author":"Dong","year":"2022","journal-title":"Cancers"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1128\/JVI.75.9.4080-4090.2001","article-title":"Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts","volume":"75","author":"Hansen","year":"2001","journal-title":"J Virol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"6484","DOI":"10.1158\/0008-5472.CAN-13-1094","article-title":"A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance","volume":"73","author":"Zhou","year":"2013","journal-title":"Cancer Res"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.molonc.2016.07.008","article-title":"A ribonucleotide reductase inhibitor with deoxyribonucleoside-reversible cytotoxicity","volume":"10","author":"Crona","year":"2016","journal-title":"Mol Oncol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/156800906777723949","article-title":"Ribonucleotide reductase inhibitors and future drug design","volume":"6","author":"Shao","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/35003506","article-title":"A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage","volume":"404","author":"Tanaka","year":"2000","journal-title":"Nature"},{"key":"bib27","first-page":"196","article-title":"Effect of hydroxyurea and etoposide on transduction of human bone marrow mesenchymal stem and progenitor cell by adeno-associated virus vectors","volume":"25","author":"Ju","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1128\/jvi.70.5.3227-3234.1996","article-title":"Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors","volume":"70","author":"Ferrari","year":"1996","journal-title":"J Virol"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.virol.2006.04.042","article-title":"Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors","volume":"353","author":"Zhao","year":"2006","journal-title":"Virology"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1128\/JVI.77.4.2741-2746.2003","article-title":"Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo","volume":"77","author":"Qing","year":"2003","journal-title":"J Virol"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41587-022-01240-2","article-title":"Fludarabine increases nuclease-free AAV- and CRISPR\/Cas9-mediated homologous recombination in mice","volume":"40","author":"Tsuji","year":"2022","journal-title":"Nat Biotechnol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-genet-051710-150955","article-title":"Regulation of homologous recombination in eukaryotes","volume":"44","author":"Heyer","year":"2010","journal-title":"Annu Rev Genet"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/hum.2005.16.522","article-title":"Gene targeting by adeno-associated virus vectors is cell-cycle dependent","volume":"16","author":"Trobridge","year":"2005","journal-title":"Human Gene Ther"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.4143\/crt.2020.289","article-title":"Effectiveness and safety of clofarabine monotherapy or combination treatment in relapsed\/refractory childhood acute lymphoblastic leukemia: a pragmatic, non-interventional study in Korea","volume":"53","author":"Choi","year":"2021","journal-title":"Cancer Res Treat"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1634\/theoncologist.2017-0658","article-title":"A phase I dose-escalation study of clofarabine in patients with relapsed or refractory low-grade or intermediate-grade B-cell or T-cell lymphoma","volume":"23","author":"Foss","year":"2018","journal-title":"Oncologist"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/cncr.25603","article-title":"Efficacy and safety of clofarabine in relapsed and\/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients","volume":"117","author":"Nabhan","year":"2011","journal-title":"Cancer"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/cncr.21005","article-title":"The role of clofarabine in hematologic and solid malignancies\u2013development of a next-generation nucleoside analog","volume":"103","author":"Faderl","year":"2005","journal-title":"Cancer"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/cncr.28674","article-title":"AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia","volume":"120","author":"Cooper","year":"2014","journal-title":"Cancer"},{"key":"bib39","first-page":"3580","article-title":"DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Clin Cancer Res"},{"key":"bib40","first-page":"2847","article-title":"Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells","volume":"55","author":"Xie","year":"1995","journal-title":"Cancer Res"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajh.25665","article-title":"Phase I\/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia","volume":"95","author":"Krakow","year":"2020","journal-title":"Am J Hematol"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3324\/haematol.2017.187153","article-title":"Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed\/refractory acute myeloid leukemia: a phase IB study","volume":"103","author":"van Eijkelenburg","year":"2018","journal-title":"Haematologica"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nrd2055","article-title":"Discovery and development of clofarabine: a nucleoside analogue for treating cancer","volume":"5","author":"Bonate","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.ymthe.2018.08.017","article-title":"Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma","volume":"26","author":"Bosco","year":"2018","journal-title":"Mol Ther"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1073\/pnas.92.12.5719","article-title":"DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors","volume":"92","author":"Russell","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4161\/cc.11.1.18775","article-title":"An integrated view of cyclin E function and regulation","volume":"11","author":"Siu","year":"2012","journal-title":"Cell Cycle (Georgetown, Tex)"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12967-014-0222-1","article-title":"Down-regulation of Sp1 suppresses cell proliferation, clonogenicity and the expressions of stem cell markers in nasopharyngeal carcinoma","volume":"12","author":"Zhang","year":"2014","journal-title":"J Transl Med"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1038\/sj.onc.1202477","article-title":"Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle","volume":"17","author":"Lauper","year":"1998","journal-title":"Oncogene"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.embor.7400624","article-title":"The functional role of Cdc6 in S-G2\/M in mammalian cells","volume":"7","author":"Lau","year":"2006","journal-title":"EMBO Rep"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12943-022-01623-8","article-title":"CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma","volume":"21","author":"Wang","year":"2022","journal-title":"Mol Cancer"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1158\/0008-5472.CAN-20-2860","article-title":"Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction","volume":"81","author":"Rieunier","year":"2021","journal-title":"Cancer Res"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2803028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:05Z","timestamp":1791927125000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2803028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.5.42","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,28]]}}}